Clinical Trial Update: Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating mogamulizumab and brentuximab vedotin in patients with cutaneous T-cell lymphoma and mycosis fun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Drugs mentioned

• Adcetris (Brentuximab vedotin)
• Poteligeo (mogamulizumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cutaneous T Cell Lymphoma, Mycosis Fungoides | Phase 1 | Status: RECRUITING